ResMed shares ticked up today on second-quarter results that came in ahead of the consensus forecast. Shares of RMD increased by 6.6% to $183.16 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose by 1%. The San Diego-based sleep respiratory device maker […]
Respiratory
FDA clears AI-based lung analysis software from Thirona
Thirona announced today that it received FDA 510(k) clearance for the latest update of its AI-based LunQ clinical software. LungQ 3.0.0 utilizes AI to automatically segment the pulmonary segments and subsegments in the internal anatomy of the lung. The analysis includes the identification of structures like lobes, segments, subsegments, airways and fissures. It analyzes the […]
ResMed CPAP masks recall is Class I
The FDA announced that ResMed’s voluntary recall of millions of CPAP mask magnets is now Class I, the agency’s most serious level. Last month, ResMed warned CPAP users about potential magnetic interference when magnets go near certain implants and medical devices in the body. People using CPAP masks with magnets only need to return […]
Report: Concerning chemicals found in replacement Philips CPAPs
Replacement machines issued by Philips amid its respiratory device recall may have more issues, according to ProPublica and the Pittsburgh Post-Gazette. Philips Respironics has recalled more than 5 million devices since 2021 due to dangerous degradation of sound abatement foam. The FDA has received more than 100,000 reports of problems related to the recall, including at […]
Inspire Medical adds Intuitive CMO Dr. Myriam Curet to its board
Inspire Medical Systems (NYSE:INSP) announced today that it appointed Dr. Myriam J. Curet as an independent board director. Curet’s appointment went into effect on Dec. 21, 2023. She currently serves as EVP and chief medical officer at surgical robotics pioneer Intuitive Surgical. Curet spoke to Medical Design & Outsourcing this year to explain the secret behind […]
Investors file class action against Inspire Medical, allege misleading statements
Two law firms in New York announced the filing of a class action lawsuit by investors against Inspire Medical Systems (NYSE:INSP). Bragar Eagel & Squire, P.C., and Bernstein Liebhard LLP filed on behalf of persons or entities who purchased or otherwise acquired Inspire Medical common stock between May 3, 2023, and Nov. 7, 2023. The […]
ResMed warns on updates to masks with magnets
ResMed announced today that it’s conducting a voluntary global field action to update guides for all masks with magnets. San Diego-based ResMed informed users of potential magnetic interference when magnets go near certain implants and medical devices in the body. The company doesn’t require a return of a mask with magnets unless the patient is […]
The top medtech trends of 2023
The top medtech trends of 2023 included innovations such as artificial intelligence, new GLP-1 weight loss drugs and some long-awaited medtech finally receiving regulatory nods. With health providers facing additional challenges on top of an ever-uncertain economic environment, medtech companies also made major readjustments: layoffs, spinoffs, reorganizations and much more. Here are the top stories […]
ResMed earns victory in patent spat with NYU
ResMed announced that it secured a victory in a patent battle with New York University. The San Diego-based respiratory device maker said the U.S. Patent Trial and Appeals Board (PTAB) invalidated NYU claims against ResMed. These claims came based on seven NYU patents. In June 2021, NYU filed a complaint for patent infringement against ResMed […]
Qnovia has positive results for inhaled smoking cessation therapy
Qnovia announced positive results from its first-in-human study for the QN-01 inhaled smoking cessation therapy. Richmond, Virginia-based Qnovia develops the RespiRx drug delivery platform that leverages a vibrating mesh nebulizer. CEO Brian Quigley explained the technology to Drug Delivery Business News last year. The company designed the QN-01 therapy to meet the need for safe and effective […]
FDA clears oral device for severe sleep apnea from Vivos Therapeutics
Vivos Therapeutics (Nasdaq:VVOS) announced today that the FDA cleared its removable CARE oral devices for treating severe obstructive sleep apnea (OSA). The CARE (complete airway repositioning and/or expansion) line includes the flagship DNA, mRNA and mmRNA oral appliances. Littleton, Colorado–based Vivos says its clearance makes it the first company bringing a clear alternative to CPAP […]